Publications scientifiques sur le VIH
Cardiovascular Risk Scores and Insulin Resistance Are Higher With Excess Visceral Abdominal Fat in People With Hiv in the Modern Antiretroviral Era
2024
K. MOUNZER , J.R. KOETHE , J.E. LAKE , M. ZOGHEIB , C.S. McGARY , B. CASH
Efficacy and Safety of 2 Fixed Doses of Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced HIV-Positive Individuals
2024
Edwin DeJesus, MD, William J. Towner, Jr, MD, Joseph C Gathe, MD, R. Brandon Cash, PharmD, and Kaitlin Anstett, PhD
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) Study Design and Baseline Characteristics
2024
Kumar, P. , Rolle, C., Henry, Z., Emu, B., Martorell, C., McKinnon, J., Slim, J., Cash, R. B. and Anstett, K., on behalf of the PROMISE-US Investigators
Impact of Tesamorelin on Cardiovascular Disease Risk Prediction Scores in Phase 3 Studies Treatment Arms: Subanalysis
2024
S. Grinspoon , L. Fourman , T Stanley , D. Benkeser , C. McGary , R.B. Cash
Intramuscular Injection vs Intravenous Infusion of Ibalizumab for HTE PWH: The Results of TMB-302
2024
Kaitlin R. Anstett , R. Brandon Cash , Anthony Mills, Mezgebe Berhe, Edwin DeJesus